Company Intelligence

Darmiyan

Darmiyan provides enterprise-grade artificial intelligence solutions, delivering specialized Early detection of Alzheimer's disease technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.

Headquarters
San Francisco, United States
Founded
2017
Employees
8
Stage
Early
Status
Active
Products
1
Reports
8
Last reviewed
Aug 2026
AI in Healthcare Early Active

Overview

What this company is, what it builds, and who it serves.

Darmiyan is a Healthcare AI company based in San Francisco, United States, founded in 2017.

Darmiyan develops early detection of Alzheimer's disease.

What it builds

Early detection of Alzheimer's disease

Why It Matters

Darmiyan provides enterprise-grade artificial intelligence solutions, delivering specialized Early detection of Alzheimer's disease technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.

Products

Products and platforms connected to this company.

  • Darmiyan Healthcare

    Explore Darmiyan by Darmiyan. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture, and FAQs.

    View product intelligence

Ecosystem

How this company connects across the Brel AI intelligence graph.

Company

Darmiyan

Industry

Products

Capabilities

  • Early detection of Alzheimer's disease

Country

United States

Related companies

Official Resources

Official and developer links on file for this company.

Frequently Asked Questions

What does Darmiyan do?

Darmiyan specializes in artificial intelligence, developing Early detection of Alzheimer's disease to support enterprise software developers and digital transformation teams with scalable, production-grade technology.

Where is Darmiyan based and when was it founded?

Darmiyan is based in United States and was founded in 2017.

What are the main products offered by Darmiyan?

The flagship platform from Darmiyan is Early detection of Alzheimer's disease, delivered primarily through b2b saas and enterprise api licensing.

Who are the primary target users of Darmiyan?

Darmiyan primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.

Sources & Verification

How this profile is verified and where the information comes from.

Verified
Last reviewed Aug 2026

Primary sources

Request a correction if you represent this company or believe information is inaccurate.